Related Experiment Video
Updated: Jul 20, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Potent, selective pyrimidinetrione-based inhibitors of MMP-13
Lawrence A Reiter1, Kevin D Freeman-Cook, Christopher S Jones
1Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. lawrence.a.reiter@pfizer.com
Abstract:
Using SAR from two related series of pyrimidinetrione-based inhibitors, compounds with potent MMP-13 inhibition and >100-fold selectivity against other MMPs have been identified. Despite high molecular weights, clogPs, and polar surface areas, the compounds are generally well absorbed and have excellent pharmacokinetic (PK) properties when dosed as sodium salts. In a rat fibrosis model, a compound from the series displayed no fibrosis at exposures many fold greater than its MMP-13 IC50.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...